376 related articles for article (PubMed ID: 26810191)
1. Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
Candido S; Di Maso M; Serraino D; McCubrey JA; Bortolus R; Zanin M; Battiston M; Salemi R; Libra M; Polesel J
Tumour Biol; 2016 Jul; 37(7):9855-63. PubMed ID: 26810191
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.
Roy R; Louis G; Loughlin KR; Wiederschain D; Kilroy SM; Lamb CC; Zurakowski D; Moses MA
Clin Cancer Res; 2008 Oct; 14(20):6610-7. PubMed ID: 18927302
[TBL] [Abstract][Full Text] [Related]
3. Urinary ADAM12 and MMP-9/NGAL complex detect the presence of gastric cancer.
Shimura T; Dagher A; Sachdev M; Ebi M; Yamada T; Yamada T; Joh T; Moses MA
Cancer Prev Res (Phila); 2015 Mar; 8(3):240-8. PubMed ID: 25591790
[TBL] [Abstract][Full Text] [Related]
4. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma.
Gerhards S; Jung K; Koenig F; Daniltchenko D; Hauptmann S; Schnorr D; Loening SA
Urology; 2001 Apr; 57(4):675-9. PubMed ID: 11306379
[TBL] [Abstract][Full Text] [Related]
5. Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.
de Bruyn M; Arijs I; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Vermeire S; Opdenakker G
J Crohns Colitis; 2015 Dec; 9(12):1079-87. PubMed ID: 26351381
[TBL] [Abstract][Full Text] [Related]
6. Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels.
Coticchia CM; Curatolo AS; Zurakowski D; Yang J; Daniels KE; Matulonis UA; Moses MA
Gynecol Oncol; 2011 Nov; 123(2):295-300. PubMed ID: 21889192
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of MMP-2, MMP-9, TIMP-1, TIMP-2, NGAL and MMP-9/NGAL complex in urine and sera from patients with bladder cancer.
Ricci S; Bruzzese D; DI Carlo A
Oncol Lett; 2015 Oct; 10(4):2527-2532. PubMed ID: 26622883
[TBL] [Abstract][Full Text] [Related]
8. Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Activity in Human Glioma Samples Predicts Tumor Presence and Clinical Prognosis.
Liu MF; Hu YY; Jin T; Xu K; Wang SH; Du GZ; Wu BL; Li LY; Xu LY; Li EM; Xu HX
Dis Markers; 2015; 2015():138974. PubMed ID: 26663949
[TBL] [Abstract][Full Text] [Related]
9. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.
Wang M; Zhang Q; Zhao X; Dong G; Li C
Crit Care; 2014 Nov; 18(6):634. PubMed ID: 25407832
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
[TBL] [Abstract][Full Text] [Related]
12. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.
Yan L; Borregaard N; Kjeldsen L; Moses MA
J Biol Chem; 2001 Oct; 276(40):37258-65. PubMed ID: 11486009
[TBL] [Abstract][Full Text] [Related]
13. Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers.
Sier CF; Casetta G; Verheijen JH; Tizzani A; Agape V; Kos J; Blasi F; Hanemaaijer R
Clin Cancer Res; 2000 Jun; 6(6):2333-40. PubMed ID: 10873084
[TBL] [Abstract][Full Text] [Related]
14. [The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].
Perrin C; Patard JJ; Jouan F; Collet N; Théoleyre S; Edeline J; Zerrouki S; Laguerre B; Bellaud-Roturaud MA; Rioux-Leclercq N; Vigneau C
Prog Urol; 2011 Nov; 21(12):851-8. PubMed ID: 22035911
[TBL] [Abstract][Full Text] [Related]
15. The levels of matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in different stages of endometriosis.
Bostanci Durmus A; Dincer Cengiz S; Yılmaz H; Candar T; Gursoy AY; Sinem Caglar G
J Obstet Gynaecol; 2019 Oct; 39(7):991-995. PubMed ID: 31177884
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G
Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963
[TBL] [Abstract][Full Text] [Related]
17. Urine Neutrophil Gelatinase-Associated Lipocalin a Possible Diagnostic Marker for Egyptian Hepatocellular Carcinoma Patients.
Abdelsameea E; Nada A; Omar N; Saleh SM; Naguib M; El-Ezawy HEM; Bakry L; Elsabaawy M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2259-2264. PubMed ID: 32856853
[TBL] [Abstract][Full Text] [Related]
18. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
Fernández CA; Yan L; Louis G; Yang J; Kutok JL; Moses MA
Clin Cancer Res; 2005 Aug; 11(15):5390-5. PubMed ID: 16061852
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of urinary molecular markers in bladder cancer.
Eissa S; Swellam M; el-Mosallamy H; Mourad MS; Hamdy NΜ; Kamel K; Zaglol AS; Khafagy MM; el-Ahmady O
Anticancer Res; 2003; 23(5b):4347-55. PubMed ID: 14666650
[TBL] [Abstract][Full Text] [Related]
20. Urinary biomarkers predict brain tumor presence and response to therapy.
Smith ER; Zurakowski D; Saad A; Scott RM; Moses MA
Clin Cancer Res; 2008 Apr; 14(8):2378-86. PubMed ID: 18413828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
